Olimel N12e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The mixture delivers a balanced profile of essential and non‑essential amino acids directly into the bloodstream. Cells absorb these amino acids and incorporate them into proteins, helping to maintain nitrogen balance, promote tissue repair, and counteract muscle loss during illness or after operative procedures.

The dose of Olimel N12e is individualized. A qualified prescriber determines the volume and rate of infusion based on the patient’s weight, metabolic needs, renal and hepatic function, and overall clinical condition. No fixed regimen is provided in the product information.

Safety data for Olimel N12e in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by the treating physician in consultation with the patient.

To order Olimel N12e, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Olimel N12e offers a comprehensive blend of ten amino acids in a ready‑to‑use sterile solution. Compared with other products such as TrophAmine or Aminoplas, it provides a similar amino acid profile but may differ in concentration, osmolarity, and packaging. Choice of product often depends on institutional protocols, compatibility with other nutrition components, and logistical considerations.

Olimel N12e must be stored refrigerated at 2‑8 °C. Keep the vials in the original packaging, protect them from light, and avoid freezing or shaking. If the product reaches room temperature, it should be used promptly and not be re‑refrigerated.

The solution is administered intravenously, typically via a peripheral or central venous catheter. It is infused as a continuous or intermittent infusion, with the rate adjusted according to the patient’s metabolic requirements and clinical response. Administration should be performed by trained healthcare personnel under aseptic conditions.

Serious risks include anaphylactic reactions, severe metabolic acidosis, hyperammonemia (especially in patients with liver dysfunction), and renal impairment. Monitoring of vital signs, blood chemistry, and organ function is essential during therapy to detect and manage these events promptly.

Patients with known hypersensitivity to any of the amino acids in the formulation should avoid Olimel N12e. Caution is also advised for individuals with severe hepatic failure, uncontrolled hyperglycemia, or those receiving incompatible intravenous solutions in the same line without proper flushing.